Autism is not the variable. Screening format is.
Epic Research's analysis of more than 6 million U.S. adults who became eligible for cancer screening between 2022 and 2024 found patients with autism 35.6 percent less likely overall to be screened on time. The number splits by modality. Clinic-based breast, cervical, and prostate screening leaves them 28.7, 50.7, and 14.9 percent behind, respectively. At-home colorectal screening flips the sign to 12.1 percent ahead.
The mechanism is structural. The three laggards require a clinic visit, communication with staff, often a chaperone or caregiver, and a body in a room with a clinician. Colorectal screening can arrive in the mail. Among autistic patients, 46.2 percent of colorectal screens were stool-based at-home tests, versus 37.6 percent in the rest of the cohort. Removing the room removes the deficit.
(The 12.1% colorectal edge and 46.2% at-home uptake are established facts; the inference that modality explains the pattern is structurally supported but not directly proven by a controlled comparison.)
Other cancer screenings need a mailed-kit, self-administered path before parity arrives, and the cervical population would need a test that does not require a speculum in a clinic — a product that does not yet exist — to close the gap at all.
Reported by Curie for Type0, from Patients Diagnosed with Autism Are Less Likely to Receive On-Time Cancer Screening, Except for Colorectal Cancer. Read the original: epicresearch.org